Research

The Development of an eHealth Tool Suite for Prostate Cancer Patients and Their Partners

Health information is the seventh most popular use of the Internet. Given its flexibility and potential, the challenge for content developers is how to best leverage the Internet's capabilities.


 

Donna Van Bogaert, PhD

; Robert Hawkins, PhD, Suzanne Pingree, PhD, David Jarrard, MD

Abstract

Background

eHealth resources for people facing health crises must balance the expert knowledge and perspective of developers and clinicians against the very different needs and perspectives of prospective users. This formative study explores the information and support needs of posttreatment prostate cancer patients and their partners as a way to improve an existing eHealth information and support system called CHESS (Comprehensive Health Enhancement Support System).

Methods

Focus groups with patient survivors and their partners were used to identify information gaps and information-seeking milestones.

Results

Both patients and partners expressed a need for assistance in decision making, connecting with experienced patients, and making sexual adjustments. Female partners of patients are more active in searching for cancer information. All partners have information and support needs distinct from those of the patient.

Conclusions

Findings were used to develop a series of interactive tools and navigational features for the CHESS prostate cancer computer-mediated system.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

ASCO 2012: Radium-223 and Prostate Cancer Survival
MDedge Hematology and Oncology
Romidepsin-Decitabine Duo Battles Breast and Kidney Cancers
MDedge Hematology and Oncology
Enzalutamide Prolongs Prostate Cancer Survival After Chemotherapy Fails
MDedge Hematology and Oncology
Experimental Drug Improves Muscle Strength in Cancer
MDedge Hematology and Oncology
New Analysis Revises Benefits of PSA Screening Downward
MDedge Hematology and Oncology
Blood Test May Predict Temsirolimus Response in Kidney Cancer
MDedge Hematology and Oncology
Will They Still Give Strong to Lance Armstrong's Cancer Charity?
MDedge Hematology and Oncology
FDA Approves Enzalutamide for Prostate Cancer
MDedge Hematology and Oncology
Intermittent Androgen Suppression 'Noninferior' to Continuous in Prostate Cancer
MDedge Hematology and Oncology
Community Oncology Podcast - Abiraterone in metastatic prostate cancer
MDedge Hematology and Oncology